Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine

Antiviral Research

Volumn 83, Issue 1, 2009, Pages 45-52

  Dory, Daniel ^a   Rémond, Michelle ^b   Béven, Véronique ^a   Cariolet, Roland ^a   Zientara, Stephan ^b   Jestin, André ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

^b INRA   (France)

Author keywords

DNA vaccination; Foot and mouth disease virus; Pigs; Sindbis virus derived plasmid

Indexed keywords

DNA VACCINE; FOOT AND MOUTH DISEASE VACCINE; NEUTRALIZING ANTIBODY; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HUMORAL IMMUNITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; SINDBIS VIRUS; SWINE;

ANIMALS; ANTIBODIES, VIRAL; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNIZATION, SECONDARY; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; NEUTRALIZATION TESTS; PLASMIDS; SINDBIS VIRUS; SWINE; VACCINES, DNA; VIRAL VACCINES;

FOOT-AND-MOUTH DISEASE VIRUS; SINDBIS VIRUS; SUIDAE;

EID: 67349285334     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.03.004     Document Type: Article

References (44)

1. Bergamin F., Saurer L., Neuhaus V., McCullough K.C., and Summerfield A. Porcine B-cell activating factor promotes anti-FMDV antibodies in vitro but not in vivo after DNA vaccination of pigs. Vet. Immunol. Immunopathol. 120 (2007) 115-123
2. Borrego B., Fernandez-Pacheco P., Ganges L., Domenech N., Fernandez-Borges N., Sobrino F., and Rodríguez F. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Vaccine 24 (2006) 3889-3899
3. Cedillo-Barrón L., Foster-Cuevas M., Belsham G.J., Lefèvre F., and Parkhouse R.M. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J. Gen. Virol. 82 (2001) 1713-1724
4. Cedillo-Barrón L., Foster-Cuevas M., Cook A., Gutiérrez-Castañeda B., Kollnberger S., Lefèvre F., and Parkhouse R.M. Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine. Vaccine 21 (2003) 4261-4269
5. Chen L., and Shao H. Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease. Vet. Immunol. Immunopathol. 109 (2006) 177-182
6. Chénard G., Miedema K., Moonen P., Schrijver R.S., and Dekker A. A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology. J. Virol. Methods 107 (2003) 89-98
7. Cox S.J., Aggarwal N., Statham R.J., and Barnett P.V. Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 21 (2003) 1336-1347
8. Dory D., Torché A.M., Béven V., Blanchard P., Loizel C., Cariolet R., and Jestin A. Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins. Vaccine 23 (2005) 3483-3491
9. Du Y., Jiang P., Li Y., He H., Jiang W., Wang X., and Hong W. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor. Vaccine 25 (2007) 8209-8219
10. Dubensky Jr. T.W., Driver D.A., Polo J.M., Belli B.A., Latham E.M., Ibanez C.E., Chada S., Brumm D., Banks T.A., Mento S.J., Jolly D.J., and Chang S.M. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J. Virol. 70 (1996) 508-519
11. Dufour V., Chevallier S., Cariolet R., Somasundaram S., Lefèvre F., Jestin A., and Albina E. Induction of porcine cytokine mRNA expression after DNA immunization and pseudorabies virus infection. J. Interferon Cytokine Res. 20 (2000) 889-895
12. Fan H., Tong T., Chen H., and Guo A. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus. Virus Genes 35 (2007) 347-357
13. Gravier R., Dory D., Laurentie M., Bougeard S., Cariolet R., and Jestin A. In vivo tissue distribution and kinetics of a pseudorabies virus plasmid DNA vaccine after intramuscular injection in swine. Vaccine 25 (2007) 6930-6938
14. Grubman M.J., and Baxt B. Foot-and-mouth disease. Clin. Microbiol. Rev. 17 (2004) 465-493
15. Guo H., Liu Z., Sun S., Bao H., Chen Y., Liu X., and Xie Q. Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. Vaccine 23 (2005) 3236-3242
16. Guo H.C., Liu Z.X., Sun S.Q., Leng Q.W., Li D., Liu X.T., and Xie Q.G. The effect of bovine IFN-alpha on the immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus. Acta Biochim. Biophys. Sin. (Shanghai) 36 (2004) 701-706
17. Hahn U.K., Alex M., Czerny C.P., Böhm R., and Beyer W. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination. Int. J. Med. Microbiol. 294 (2004) 35-44
18. Hariharan M.J., Driver D.A., Townsend K., Brumm D., Polo J.M., Belli B.A., Catton D.J., Hsu D., Mittelstaedt D., McCormack J.E., Karavodin L., Dubensky Jr. T.W., Chang S.M., and Banks T.A. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J. Virol. 72 (1998) 950-958
19. Kim S.A., Liang C.M., Cheng I.C., Cheng Y.C., Chiao M.T., Tseng C.J., Lee F., Jong M.H., Tao M.H., Yang N.S., and Liang S.M. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. J. Gene Med. 8 (2006) 1182-1191
20. King A.M., Underwood B.O., McCahon D., Newman J.W., and Brown F. Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK. Nature 293 (1981) 479-480
21. Kirman J.R., Turon T., Su H., Li A., Kraus C., Polo J.M., Belisle J., Morris S., and Seder R.A. Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A. Infect. Immun. 71 (2003) 575-579
22. Leitner W.W., Ying H., Driver D.A., Dubensky T.W., and Restifo N.P. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res. 60 (2000) 51-55
23. Leitner W.W., Ying H., and Restifo N.P. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 18 (1999) 765-777
24. Li Y., Aggarwal N., Takamatsu H.H., Sterling C.M., Voyce C., and Barnett P.V. Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O. Vaccine 24 (2006) 4602-4606
25. Loizel C., Blanchard P., Grasland B., Dory D., Oger A., Nignol A.C., Cariolet R., and Jestin A. Effect of granulocyte-macrophage colony-stimulating factor on post-weaning multisystemic wasting syndrome in porcine circovirus type-2-transfected piglets. Int. J. Exp. Pathol. 86 (2005) 33-43
26. Mann H.B., and Whitney D.R. On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat. 18 (1947) 50-60
27. Mingxiao M., Ningyi J., Juan L.H., Min Z., Guoshun S., Guangze Z., Huijun L., Xiaowei H., Minglan J., Xu L., Haili M., Yue J., Gefen Y., and Kuoshi J. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18. Antiviral Res. 76 (2007) 59-67
28. Niborski V., Li Y., Brennan F., Lane M., Torché A.M., Remond M., Bonneau M., Riffault S., Stirling C., Hutchings G., Takamatsu H., Barnett P., Charley B., and Schwartz-Cornil I. Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV. Vaccine 24 (2006) 7204-7213
29. OIE, 2000. OIE Manual of Standards for diagnostics tests and vaccines, fourth edition.
30. Park J.H., Kim S.J., Oem J.K., Lee K.N., Kim Y.J., Kye S.J., Park J.Y., and Joo Y.S. Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes. J. Vet. Sci. 7 (2006) 257-262
31. Peachman K.K., Rao M., and Alving C.R. Immunization with DNA through the skin. Methods 31 (2003) 232-242
32. Raz E., Carson D.A., Parker S.E., Parr T.B., Abai A.M., Aichinger G., Gromkowski S.H., Singh M., Lew D., Yankauckas M.A., Baird S.M., and Rhodes G.H. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9519-9523
33. Rodrigo M.J., and Dopazo J. Evolutionary analysis of the picornavirus family. J. Mol. Evol. 40 (1995) 362-371
34. Ryan M.D., Belsham G.J., and King A.M. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology 173 (1989) 35-45
35. Serafini P., Carbley R., Noonan K.A., Tan G., Bronte V., and Borrello I. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64 (2004) 6337-6343
36. Sobrino F., Sáiz M., Jiménez-Clavero M.A., Núñez J.I., Rosas M.F., Baranowski E., and Ley V. Foot-and-mouth disease virus: a long known virus, but a current threat. Vet. Res. 32 (2001) 1-30
37. Somasundaram C., Takamatsu H., Andréoni C., Audonnet J.C., Fisher L., Lefèvre F., and Charley B. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. Vet. Immunol. Immunopathol. 70 (1999) 277-287
38. Stellmann C., Vannier P., Chappuis G., Brun A., Dauvergne M., Frageaud D., Bugand M., and Colson X. The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement. J. Biol. Stand. 17 (1989) 17-27
39. The Veterinary Record. FMD outbreak linked to defective drain. Vet. Rec. 161 (2007) 362-363
40. Wong H.T., Cheng S.C., Sin F.W., Chan E.W., Sheng Z.T., and Xie Y. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine 20 (2002) 2641-2647
41. Xiao C., Jin H., Hu Y., Kang Y., Wang J., Du X., Yang Y., She R., and Wang B. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants. Antiviral Res. 76 (2007) 11-20
42. Yin W., Xiang P., and Li Q. Investigations of the effect of DNA size in transient transfection assay using dual luciferase system. Anal. Biochem. 346 (2005) 289-294
43. Zhang H.Y., Sun S.H., Guo Y.J., Zhou F.J., Chen Z.H., Lin Y., and Shi K. Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus. Vaccine 21 (2003) 4704-4707
44. Zhu W., Thomas C.E., and Sparling P.F. DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment. Vaccine 22 (2004) 660-669